Category: Finance
-
Grant to Fund Research on Biodegradable Implant Materials
The engineering school at University of California in Riverside has received funding for research on alternative materials for medical implants that degrade naturally. National Science Foundation awarded the two-year grant for $175,000 to assistant professor of bioengineering Huinan Liu. Liu’s research will focus on developing biodegradable medical implant materials that would promote tissue regeneration and…
-
Dow Chemical to Invest $25 Million in Universities
Dow Chemical Company in New York said today it plans to invest $25 million in U.S. university research and education programs over the next 10 years. Dow also announced a collaboration with Argonne National Lab on advanced battery materials. The company says its university funding will support faculty, students and infrastructure at 11 campuses in…
-
New On Technorati: Friendly to What Business?
High paying jobs are being created in large numbers right here in the U.S., and in places where the so-called experts say they’re not supposed to happen. If states want the big bucks from big brains and the benefits they bring, then they need to make the work being done and people doing the work…
-
Small Business Grant Awarded for Bone Marrow Protection Drug
A company in Chapel Hill, North Carolina has received a $3 million grant from NIH to commercialize a therapy to protect bone marrow in cancer patients against damage from chemo and radiation therapy. G-Zero Therapeutics received the Small Business Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases. The award to…
-
USDA Funding Forest, Grasses Biofuel Research
The National Institute of Food and Agriculture, a division of the U.S. Department of Agriculture, announced $137 million in grants for research on biofuels from tall grasses, crop residues, and forest resources. The five-year awards will go to 22 universities and companies, through the lead institutions in Washington, Louisiana, Tennessee, and Iowa. The grants will…
-
Genomics Consortium Adds Two Members, Gains $49 Million
The Structural Genomics Consortium (SGC) says it added two new pharmaceutical companies as members and $48.9 million in new funding. The partnership of drug companies and science funding agencies conducts basic drug discovery research, with its findings released to the public domain. SGC added Eli Lilly Canada and Pfizer Inc. to its membership that also…
-
Semiconductor Companies to Invest $4.4B in New York R&D
Five semiconductor developers said today they will make a joint investment of $4.4 billion over the next five years to develop new computer chip technologies in New York State. The companies include Intel Corporation, IBM, GlobalFoundries, Samsung, and Taiwan Semiconductor Manufacturing Company (TSMC). The investments will be made in current and upgraded facilities in Albany,…
-
DoE Science Review Boosts Transport, Grid, Quicker Payoffs
The U.S. Department of Energy (DoE) today released its first Quadrennial Technology Review report, an assessment of the Department’s technology research and development portfolios. The report urges the department to focus its R&D more on transportation than stationary energy production, grid modernization, and technologies closer to fruition than is now often the case. The report…
-
Drug Company Stock Prices Linked to Cancer Trial Results
A study indicates that changes in stock prices of companies in phase 3 clinical trials of their cancer drugs were associated with the outcomes of those trials in the period before the results were publicly announced. The findings of Allan Desky of Mount Sinai Hospital in Toronto, Canada and colleagues appear online in the Journal…
-
Roche, Canadian Not-for-Profit to Partner on New Drugs
The Centre for Drug Research and Development (CDRD) in Vancouver, Canada and Swiss pharmaceutical maker F. Hoffmann-La Roche Ltd. have agreed to collaborate on development and commercialization of new drug therapies. The exact therapies are yet to be defined, according to the announcement, but will be “for the treatment of diseases with high unmet medical…